Inovio’s upside hinges on INO-3107 for HPV-6/11 RRP with FDA PDUFA Oct 2026, regulatory risk, tight cash, and cheap EV. Check ...

Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics: Lille, France Saturd ...

As of Friday, January 09, Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 5.01%, which has investors questioning ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

The submission follows a Type C meeting with the FDA in December 2025 to discuss the proposed accelerated approval pathway. The amendment is supported by positive final results from the company’s ...

In peer-reviewed study on mice, Technion scientists say novel method using harmless microneedle patches opens the door to ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

Massachusetts-based biopharma companies secured $6.85B in venture capital funding in 2025, the lowest since 2019, according to a new report.

Dogs fed on premium, meat-rich pet food can have a bigger dietary carbon footprint than their owners, a new study has found.

Visakhapatnam: Andhra University has been sanctioned the AU-BioNEST Bio-Incubation Centre. The centre will be established ...

In December, the FDA approved the once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the US. Manufacturing ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...